Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BCAX
BCAX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BCAX News
Bicara Therapeutics Reports New Data Showing Ficerafusp Alfa Significantly Improves Survival Rates
6d ago
Newsfilter
Omega Fund Increases Stake in Bicara Therapeutics
May 16 2026
Fool
Bicara Therapeutics Appoints New CCO and Grants Stock Options
May 13 2026
Newsfilter
Bicara (BCAX) Q1 2026 Earnings Transcript
May 11 2026
NASDAQ.COM
Bicara Therapeutics Reports Q1 2026 Financial Results and Updates
May 11 2026
Newsfilter
Bicara Therapeutics CMO Executes Stock Sale
May 04 2026
Fool
Bicara Therapeutics to Report Q1 2026 Financial Results and Host Conference Call
May 04 2026
Newsfilter
Bicara Therapeutics Grants Stock Options to New Employee
Apr 03 2026
Newsfilter
Bicara Therapeutics CEO Sells Stock Options
Mar 30 2026
Fool
Bicara Therapeutics CEO Sells Shares Amid Strong Stock Performance
Mar 30 2026
NASDAQ.COM
Bicara Therapeutics Reports Q4 2025 Financial Results
Mar 30 2026
seekingalpha
Bicara Therapeutics Advances Ficerafusp Alfa in Clinical Trials
Mar 30 2026
Newsfilter
BICARA THERAPEUTICS INC Reports Q4 Net Loss of $37.4 Million; FY2025 Net Loss Totals $138.0 Million
Mar 30 2026
moomoo
BICARA THERAPEUTICS BEGINS PHASE 3 OF FORTIFI-HN01 KEY TRIAL; INTERIM RESULTS ANTICIPATED BY MID-2027
Mar 30 2026
moomoo
Key Stock Market Movers: Nvidia, Eli Lilly, Alcoa, Coinbase, and Strategic Developments
Mar 30 2026
Barron's
Bicara CEO Sells Shares Under 10b5-1 Plan
Mar 26 2026
Fool
Show More News
